Editorial Board
29 January 2011 | page i
Viewing articles 1-7 of 7
Reevaluating the Health-Related Quality of Life Impact and the Economic Burden of Urgency Urinary Incontinence
29 January 2011 | pages 3 - 7
Understanding Dose Titration: Overactive Bladder Treatment With Fesoterodine as an Example
29 January 2011 | pages 8 - 13
Fesoterodine: Individualised Treatment of Urgency Urinary Incontinence Across Patient Groups
29 January 2011 | pages 14 - 22
The Patient-Centric Approach: The Importance of Setting Realistic Treatment Goals
29 January 2011 | pages 23 - 27
Viewing articles 1-7 of 7